Skip to main content
OpenTrials

Clinical trial condition

Diffuse Midline Glioma, H3 K27M-Mutant

Explore clinical trials studying Diffuse Midline Glioma, H3 K27M-Mutant. Study availability and eligibility vary by location and protocol.

21 public trials 15 recruiting studies
Refine in advanced search Browse all conditions

Diffuse Midline Glioma, H3 K27M-Mutant trial results

Recruiting

Combination Therapy for the Treatment of Diffuse Midline Gliomas

NCT05009992

Conditions
Brain Diseases, Brain Neoplasms, Brain Stem Neoplasms, +20 more
Locations
  • University of Alabama at Birmingham Birmingham, Alabama, United States
  • Children's Hospital Los Angeles Los Angeles, California, United States
  • University of California, San Diego / Rady Children's Hospital, San Diego San Diego, California, United States
  • University of California, San Francisco San Francisco, California, United States
View all 32 locations
View Trial Details
Recruiting

Study of Olutasidenib and Temozolomide in HGG

NCT06161974

Conditions
Astrocytoma, Astrocytoma, Grade III, Astrocytoma, Grade IV, +36 more
Locations
  • Children's Hospital Colorado Aurora, Colorado, United States
  • Children's National Medical Center Washington D.C., District of Columbia, United States
  • University of Miami Hospital and Clinics Miami, Florida, United States
  • Ann & Robert H. Lurie Children's Hospital of Chicago Chicago, Illinois, United States
View all 20 locations
View Trial Details
Recruiting

Targeted Pediatric High-Grade Glioma Therapy

NCT05839379

Conditions
Anaplastic Astrocytoma, Astrocytoma, Brain Diseases, +24 more
Locations
  • Children's Hospital Colorado Aurora, Colorado, United States
  • Children's National Medical Center Washington D.C., District of Columbia, United States
  • Ann & Robert H. Lurie Children's Hospital of Chicago Chicago, Illinois, United States
  • Dana-Farber Cancer Institute Boston, Massachusetts, United States
View all 21 locations
View Trial Details
Recruiting

Study of Ribociclib and Everolimus in HGG and DIPG or Ribociclib and Temozolomide in DHG, H3G34-mutant

NCT05843253

Conditions
Anaplastic Astrocytoma, Astrocytoma, Brain Diseases, +25 more
Locations
  • Children's Hospital Colorado Aurora, Colorado, United States
  • Children's National Medical Center Washington D.C., District of Columbia, United States
  • Ann & Robert H. Lurie Children's Hospital of Chicago Chicago, Illinois, United States
  • Dana-Farber Cancer Institute Boston, Massachusetts, United States
View all 20 locations
View Trial Details
Recruiting

Biological Medicine for Diffuse Intrinsic Pontine Glioma (DIPG) Eradication 2.0

NCT05476939

Conditions
Brain Diseases, Brain Neoplasms, Brain Stem Neoplasms, +17 more
Locations
  • Aarhus Universitetshospital Skejby Aarhus, Denmark
  • Rigshospitalet Copenhagen, Denmark
  • H.C. Andersen Children's Hospital, Odense Universitetshospital Odense, Denmark
  • Gustave Roussy Villejuif, Val de Marne, France
View all 50 locations
View Trial Details
Recruiting

FUS Etoposide for DMG

NCT05762419

Conditions
Brain Diseases, Brain Neoplasms, Brain Stem Neoplasms, +16 more
Locations
  • Columbia University Irving Medical Center New York, United States
View Trial Details

Related conditions